JPRN-UMIN000017232
Completed
未知
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer. - A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.
Conditionsterine cervical cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- terine cervical cancer
- Sponsor
- Osaka University Hospital
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •FIGO stage Ia\-IIIa cervical cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
Completed
Phase 2
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
Completed
Not Applicable
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancerJPRN-UMIN000010324orth Japan Lung Cancer Study Group35
Completed
Phase 2
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
Recruiting
Phase 2
Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.Squamous cell carcinoma of the lungJPRN-UMIN000009308Kyoto Thoracic Oncology Research Group35